Select Medical Holdings Co. (NYSE:SEM) to Post FY2023 Earnings of $1.95 Per Share, Zacks Research Forecasts

Select Medical Holdings Co. (NYSE:SEMFree Report) – Analysts at Zacks Research cut their FY2023 EPS estimates for Select Medical in a note issued to investors on Monday, January 15th. Zacks Research analyst D. Chatterjee now anticipates that the health services provider will earn $1.95 per share for the year, down from their prior estimate of $1.96. The consensus estimate for Select Medical’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Select Medical’s Q4 2023 earnings at $0.32 EPS, Q2 2024 earnings at $0.58 EPS, Q3 2024 earnings at $0.48 EPS, Q4 2024 earnings at $0.56 EPS, FY2024 earnings at $2.21 EPS, Q1 2025 earnings at $0.69 EPS, Q2 2025 earnings at $0.63 EPS and FY2025 earnings at $2.69 EPS.

A number of other research analysts have also recently issued reports on SEM. TheStreet cut shares of Select Medical from a “b-” rating to a “c+” rating in a research report on Friday, November 3rd. Benchmark reiterated a “buy” rating and set a $39.00 target price on shares of Select Medical in a report on Wednesday, November 8th. StockNews.com initiated coverage on Select Medical in a research note on Thursday, October 5th. They issued a “buy” rating on the stock. Finally, UBS Group began coverage on Select Medical in a research note on Thursday, November 30th. They set a “neutral” rating and a $26.00 price objective for the company. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $34.40.

Check Out Our Latest Stock Analysis on Select Medical

Select Medical Price Performance

SEM opened at $25.94 on Tuesday. The stock has a fifty day simple moving average of $24.02 and a two-hundred day simple moving average of $26.04. The company has a market cap of $3.33 billion, a price-to-earnings ratio of 14.60, a price-to-earnings-growth ratio of 0.53 and a beta of 1.32. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 2.43. Select Medical has a 12-month low of $21.28 and a 12-month high of $33.51.

Select Medical (NYSE:SEMGet Free Report) last announced its earnings results on Thursday, November 2nd. The health services provider reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.08. Select Medical had a net margin of 3.41% and a return on equity of 16.19%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.59 billion.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 28th. Shareholders of record on Wednesday, November 15th were paid a dividend of $0.125 per share. The ex-dividend date of this dividend was Tuesday, November 14th. This represents a $0.50 annualized dividend and a yield of 1.93%. Select Medical’s dividend payout ratio is 28.25%.

Insiders Place Their Bets

In other Select Medical news, Chairman Robert A. Ortenzio sold 100,000 shares of the business’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $26.63, for a total value of $2,663,000.00. Following the completion of the transaction, the chairman now owns 6,839,668 shares of the company’s stock, valued at approximately $182,140,358.84. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 19.14% of the company’s stock.

Institutional Investors Weigh In On Select Medical

A number of large investors have recently added to or reduced their stakes in SEM. Avior Wealth Management LLC purchased a new position in shares of Select Medical in the 3rd quarter worth $25,000. Mitsubishi UFJ Trust & Banking Corp bought a new stake in shares of Select Medical during the 3rd quarter valued at about $29,000. Geneos Wealth Management Inc. purchased a new stake in shares of Select Medical during the 3rd quarter valued at about $30,000. Quarry LP bought a new position in shares of Select Medical in the 2nd quarter worth approximately $30,000. Finally, Harbor Capital Advisors Inc. purchased a new position in shares of Select Medical in the second quarter worth approximately $38,000. Institutional investors own 76.95% of the company’s stock.

About Select Medical

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: The Critical Illness Recovery Hospital, The Rehabilitation Hospital, The Outpatient Rehabilitation, and The Concentra.

Recommended Stories

Earnings History and Estimates for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.